Global Autoimmune Drugs Market 2024-2028

Global Autoimmune Drugs Market 2024-2028


Global Autoimmune Drugs Market 2024-2028

The autoimmune drugs market is forecasted to grow by USD 33218.8 mn during 2023-2028, accelerating at a CAGR of 6.78% during the forecast period. The report on the autoimmune drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by strong R&D pipeline, targeted therapeutic mechanism of biologics, and introduction of affordable biosimilars.

Technavio's autoimmune drugs market is segmented as below:
  • By Therapy Area
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Psoriasis
  • Inflammatory bowel disease
  • Others
  • By Distribution Channel
  • Hospital
  • Pharmacy
  • Drug store/Retail pharmacy
  • Online
  • By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the reduction in cost of autoimmune drugs as one of the prime reasons driving the autoimmune drugs market growth during the next few years. Also, market dominance by TNF-alpha inhibitors and development and approval of new drugs will lead to sizable demand in the market.

The report on the autoimmune drugs market covers the following areas:
  • Autoimmune drugs market sizing
  • Autoimmune drugs market forecast
  • Autoimmune drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autoimmune drugs market vendors that include AbbVie Inc., AdvaCare Pharma, Amgen Inc., AstraZeneca PLC, Bristol Myers Squibb Co., Cardinal Health Inc., Delphis Pharmaceutical India, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Johnson and Johnson Services Inc., Medexus Pharmaceuticals Inc., Parvus Therapeutics Inc., Prometheus Laboratories, Regeneron Pharmaceuticals Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Wellona Pharma. Also, the autoimmune drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.


  • Executive Summary
    • Market overview
      • Table Executive Summary - Data Table on Market Overview
      • Table Executive Summary - Data Table on Incremental Growth
  • Market Landscape
    • Market ecosystem
      • Table Data Table on - Parent Market
    • Market characteristics
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2023
    • Market outlook: Forecast for 2023-2028
      • Table Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Historic Market Size
    • Global Autoimmune Drugs Market 2018 - 2022
      • Table Historic Market Size - Data Table on Global Autoimmune Drugs Market 2018 - 2022 ($ million)
    • Therapy Area segment analysis 2018 - 2022
    • Distribution Channel segment analysis 2018 - 2022
    • Geography segment analysis 2018 - 2022
    • Country segment analysis 2018 - 2022
  • Five Forces Analysis
    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Therapy Area
    • Market segments
      • Table Data Table on Therapy Area - Market share 2023-2028 (%)
    • Comparison by Therapy Area
      • Table Data Table on Comparison by Therapy Area
    • Rheumatoid arthritis - Market size and forecast 2023-2028
      • Table Data Table on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
    • Multiple sclerosis - Market size and forecast 2023-2028
      • Table Data Table on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
    • Psoriasis - Market size and forecast 2023-2028
      • Table Data Table on Psoriasis - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Psoriasis - Year-over-year growth 2023-2028 (%)
    • Inflammatory bowel disease - Market size and forecast 2023-2028
      • Table Data Table on Inflammatory bowel disease - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Inflammatory bowel disease - Year-over-year growth 2023-2028 (%)
    • Others - Market size and forecast 2023-2028
      • Table Data Table on Others - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Others - Year-over-year growth 2023-2028 (%)
    • Market opportunity by Therapy Area
      • Table Data Table on Market opportunity by Therapy Area ($ million)
  • Market Segmentation by Distribution Channel
    • Market segments
      • Table Data Table on Distribution Channel - Market share 2023-2028 (%)
    • Comparison by Distribution Channel
      • Table Data Table on Comparison by Distribution Channel
    • Hospital - Market size and forecast 2023-2028
      • Table Data Table on Hospital - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Hospital - Year-over-year growth 2023-2028 (%)
    • Pharmacy - Market size and forecast 2023-2028
      • Table Data Table on Pharmacy - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Pharmacy - Year-over-year growth 2023-2028 (%)
    • Drug store/retail pharmacy - Market size and forecast 2023-2028
      • Table Data Table on Drug store/retail pharmacy - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Drug store/retail pharmacy - Year-over-year growth 2023-2028 (%)
    • Online - Market size and forecast 2023-2028
      • Table Data Table on Online - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Online - Year-over-year growth 2023-2028 (%)
    • Market opportunity by Distribution Channel
      • Table Data Table on Market opportunity by Distribution Channel ($ million)
  • Customer Landscape
    • Customer landscape overview
  • Geographic Landscape
    • Geographic segmentation
      • Table Data Table on Market share by geography 2023-2028 (%)
    • Geographic comparison
      • Table Data Table on Geographic comparison
    • North America - Market size and forecast 2023-2028
      • Table Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on North America - Year-over-year growth 2023-2028 (%)
    • Europe - Market size and forecast 2023-2028
      • Table Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • Asia - Market size and forecast 2023-2028
      • Table Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • Rest of World (ROW) - Market size and forecast 2023-2028
      • Table Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • US - Market size and forecast 2023-2028
      • Table Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on US - Year-over-year growth 2023-2028 (%)
    • Germany - Market size and forecast 2023-2028
      • Table Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • Canada - Market size and forecast 2023-2028
      • Table Data Table on Canada - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • China - Market size and forecast 2023-2028
      • Table Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on China - Year-over-year growth 2023-2028 (%)
    • UK - Market size and forecast 2023-2028
      • Table Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on UK - Year-over-year growth 2023-2028 (%)
    • Market opportunity by geography
      • Table Data Tables on Market opportunity by geography ($ million)
  • Drivers, Challenges, and Opportunity/Restraints
    • Market drivers
      • Strong R and D pipeline
      • Targeted therapeutic mechanism of biologics
      • Introduction of affordable biosimilars
    • Market challenges
      • High cost of biologics
      • Limitation of autoimmune disease diagnostics
      • Reimbursement challenges of autoimmune drugs
    • Impact of drivers and challenges
    • Market opportunities/restraints
      • Reduction in cost of autoimmune drugs
      • Market dominance by TNF-alpha inhibitors
      • Development and approval of new drugs
  • Competitive Landscape
    • Overview
    • Competitive Landscape
    • Landscape disruption
    • Industry risks
  • Competitive Analysis
    • Companies profiled
    • Market positioning of companies
    • AbbVie Inc.
    • Amgen Inc.
    • AstraZeneca Plc
    • Bristol Myers Squibb Co.
    • Cardinal Health Inc.
    • Delphis Pharmaceutical India
    • Eli Lilly and Co.
    • F. Hoffmann La Roche Ltd.
    • GlaxoSmithKline Plc
    • Hikma Pharmaceuticals Plc
    • Johnson and Johnson Services Inc.
    • Parvus Therapeutics Inc.
    • Sanofi SA
    • Takeda Pharmaceutical Co. Ltd.
    • Teva Pharmaceutical Industries Ltd.
  • Appendix
    • Scope of the report
      • Market definition
      • Objectives
      • Notes and caveats
    • Inclusions and exclusions checklist
    • Currency conversion rates for US$
    • Research methodology
    • Data procurement
    • Data validation
    • Validation techniques employed for market sizing
    • Data synthesis
    • 360 degree market analysis
    • List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings